US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

  • 1.8200
  • +0.0500+2.82%
Close Apr 19 16:00 ET
  • 1.8200
  • 0.00000.00%
Post 18:45 ET
5.59MMarket Cap-2192P/E (TTM)

About Sonnet BioTherapeutic Company

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.

Company Profile

Company NameSonnet BioTherapeutic
Listing DateJun 21, 2012
CEODr. Pankaj Mohan, PhD
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address100 Overlook Center,Suite 102
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pankaj Mohan, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 1.01M
  • Susan Dexter
  • Chief Technical Officer
  • --
  • Dr. Richard Kenney, M.D.
  • Chief Medical Officer
  • --
  • John H. Cross
  • Chief Financial Officer and Principal Accounting Officer
  • 604.81K
  • Dr. John K. Cini, PhD
  • Chief Scientific Officer
  • 614.98K
  • Donald J. Griffith
  • Director
  • 141.38K
  • Albert D. Dyrness
  • Independent Director
  • 61.87K
  • Lori McNeill
  • Independent Director
  • --
  • Raghu Rao
  • Independent Director
  • 62.87K
  • Nailesh Bhatt
  • Independent Director
  • 60.37K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price